Early intraventricular baclofen therapy (IVB) for children with dystonic and dysautonomic storm.

Abstract

INTRODUCTION:

Intrathecal baclofen (ITB) is an effective treatment for managing primary and secondary dystonia. Intraventricular baclofen (IVB) was first developed to allow treating patients in which the use of ITB was difficult due to anatomic anomalies. After that, several studies indicate that intraventricular administration of baclofen, is more effective than ITB in refractory dystonia.

CLINICAL MATERIAL:

We report three cases of children with acute dystonic and dysautonomic storm, treated with IVB. The clinical outcome was satisfactory. The response to the treatment continued after the pump disconnection, suggesting that in this kind of cerebral dysregulations, short-term IVB is an effective treatment.

CONCLUSION:

Early treatment with IVB may be an effective option in patients with post-anoxic dysautonomic and dystonic storm.

• Authors: Claudio Ruggiero, Giulia Meccariello, Pietro Spennato, Giuseppe Mirone, Stefania Graziano, Marco Gilone, Giuseppe Cinalli
• Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (Childs Nerv Syst) Vol. 35 Issue 1 Pg. 15-18 (01 2019) ISSN: 1433-0350 [Electronic] Germany
• PMID: 30417210 (Publication Type: Case Reports, Journal Article)

Chemical References

• Muscle Relaxants, Central
• Baclofen

Topics

• Adolescent
• Autonomic Nervous System Diseases (complications, drug therapy)
• Baclofen (administration & dosage, adverse effects, therapeutic use)
• Child
• Dystonia (complications, drug therapy)
• Female
• Humans
• Hypoxia, Brain (complications)
• Infusion Pumps, Implantable
• Injections, Intraventricular
• Male
• Muscle Relaxants, Central (administration & dosage, adverse effects, therapeutic use)
• Secondary Prevention
• Treatment Outcome